Molecular Neurobiology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of IJMS focuses on publishing high-quality manuscripts that report on a broad range of topics of general interest to those working in the field of molecular neurobiology. Topics include, but are not limited to, the following:
- Neurobiology
- Neurochemistry
- Neurology
- Neuropathology
- Neurophysiology
- Neuropharmacology
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Ischemic Brain Neurodegeneration (Deadline: 30 April 2021)
- Sodium Voltage-Operated Neural Channel Modulators in Peripheral Nervous System Disorders (Deadline: 30 April 2021)
- Brain Diseases: on Signaling Pathways and Miswired Networks (Deadline: 30 April 2021)
- Neurobiological Response of Thalamus to Stress or Trauma (Deadline: 30 April 2021)
- Molecular Mechanisms of Neuropathic Pain and Nerve Injury (Deadline: 30 April 2021)
- Pathogenesis and Treatment of Autism Spectrum Disorders (Deadline: 30 April 2021)
- Gender Related Molecular Mechanisms in Neurological Disorders (Deadline: 30 April 2021)
- Physiological or Pathological Molecular Alterations in Brain Aging (Deadline: 30 April 2021)
- New Molecular Insights into Neurocutaneous Syndromes (Deadline: 30 April 2021)
- Brain Mechanisms of Sleep Related Disorders (Deadline: 30 April 2021)
- GABAergic and Glycinergic Neurons (Deadline: 30 April 2021)
- Hypothalamic Regulation of Obesity (Deadline: 30 April 2021)
- Control of Astrocytes Function and Phenotype: Role in Neuropathology (Deadline: 30 April 2021)
- Neurogenetics in Neurology (Deadline: 30 April 2021)
- Glial Ion Channels and Transporters in Health and Disease (Deadline: 30 April 2021)
- Biomarkers for Meningioma (Deadline: 30 April 2021)
- Synaptic Transmission and Protein Interaction (Deadline: 30 April 2021)
- Epigenetic Regulation in Human Brain (Deadline: 30 April 2021)
- Molecular Mechanisms of Neural Stem Cells (NSC) Development - Systems Approach (Deadline: 30 April 2021)
- Neuronal Control of Locomotion (Deadline: 30 April 2021)
- Protein Kinases and Their Inhibitors in CNS Diseases (Deadline: 30 April 2021)
- Retinal Ganglion Cells 2.0 (Deadline: 15 May 2021)
- The Molecular Basis of Therapeutic Resistance of Brain Tumor (Deadline: 15 May 2021)
- Molecular Research on Rett Syndrome and Related Disorders (Deadline: 28 May 2021)
- Cellular and Molecular Mechanisms in Neurodevelopmental Disorders and Brain Tumors (Deadline: 31 May 2021)
- Advances in Knowledge in Niemann-Pick Disease Type C: Facts and Perspectives- 2nd Edition (Deadline: 31 May 2021)
- Glial Cells and Energy Intake: A Field That Is Gaining Weight (Deadline: 31 May 2021)
- Neurobiological Mechanisms Implicated in Stress-Related Psychiatric Disorders (Deadline: 31 May 2021)
- Trace Amine-Associated Receptors in Neuropsychiatric Disorders (Deadline: 31 May 2021)
- Molecular Mechanisms Underlying CNS Inflammation (Deadline: 31 May 2021)
- Molecular Insights in Psychiatry (Deadline: 31 May 2021)
- Molecular Mechanisms of Alzheimer’s Disease and Brain Tolerance (Deadline: 31 May 2021)
- Neurobiological Mechanisms of Orofacial Chronic Pain (Deadline: 31 May 2021)
- Effects of Hormones on the Nervous System and Behavior (Deadline: 31 May 2021)
- Epigenetic Regulation in Neurodegeneration Disease (Deadline: 31 May 2021)
- Neural Crest Development in Health and Disease (Deadline: 31 May 2021)
- The Mechanisms Regulation of the Neuromuscular Dysfunctions (Deadline: 31 May 2021)
- Neuroinflammation: From Molecular Mechanisms to Therapeutic Perspectives (Deadline: 31 May 2021)
- Cellular and Molecular Mechanisms of Traumatic Brain Injury and Concussion (Deadline: 20 June 2021)
- Molecular Mechanisms of Aging-Related Neurodegenerative Diseases (Deadline: 30 June 2021)
- Skeletal Muscle Denervation (Deadline: 30 June 2021)
- Molecular Mechanisms of Cerebrovascular Diseases (Deadline: 30 June 2021)
- Molecular Mechanisms and Treatments of Dependence and Neurotoxicity of Amphetamine-Type Stimulants (Deadline: 30 June 2021)
- Redox Active Metals in Neurodegenerative Diseases: Therapeutic Implications (Deadline: 30 June 2021)
- Common Chronic Diseases: Gap for the Treatment (Deadline: 30 June 2021)
- Neural Signaling, Neuromodulation and Plasticity (Deadline: 30 June 2021)
- Glycome and Nervous System (Deadline: 30 June 2021)
- Molecular Mechanisms of Synaptic Plasticity (3.0): Genetic and Environmental Factors Involved in Neuronal Changes (Deadline: 30 June 2021)
- Chronic Pain: Spinal and Sovraspinal Neuroinflammation and Associated Negative Affective States-2nd Edition (Deadline: 30 June 2021)
- Genomics of Brain Disorders 3.0 (Deadline: 30 June 2021)
- The Link between Autophagy, Axonal Function, and Metabolic Impact in Neurodegenerative Diseases (Deadline: 30 June 2021)
- Epilepsy and Comorbidities in Children: Pathogenesis, Diagnosis and Therapies (Deadline: 30 June 2021)
- Precision Medicine and Therapy for Neurodegenerative Disorders (Deadline: 30 June 2021)
- Dementia and Cell Theraputic Strategies (Deadline: 30 June 2021)
- Molecular Mechanisms of Brain Repair and Restoration after Stroke (Deadline: 1 July 2021)
- Gene Therapy for Neurodegenerative Disease (Deadline: 15 July 2021)
- Molecular Mechanisms and Neural Correlates of General Anesthesia-2nd Edition (Deadline: 30 July 2021)
- Direct Genetic Conversion of Glia Cells to Neurons (Deadline: 31 July 2021)
- Brain/Mind Activity and Molecular Dynamics in Biological Systems (Deadline: 31 July 2021)
- Synaptic Plasticity and Diseases (Deadline: 31 July 2021)
- Understanding the Impacts of Neurodevelopmental Cannabinoid Exposure (Deadline: 31 July 2021)
- Therapeutic Potential of Targeting the Oxytocinergic System (Deadline: 31 July 2021)
- Molecular Pathogenesis of Neurodegeneration: From Fish to Human (Deadline: 31 July 2021)
- Non-genetic Modifiers of Synaptic Plasticity and Neurotransmission in the Central Nervous System (CNS) in Health and Disease (Deadline: 31 July 2021)
- Choroid Plexus: Novel Functions for an Old Structure 2.0 (Deadline: 31 July 2021)
- Molecular and Cellular Mechanisms of Synchronization within the Mammalian Circadian System (Deadline: 31 July 2021)
- Role of Tau Protein in Synaptic Deteriorarion of Alzheimer's Disease (AD) (Deadline: 31 July 2021)
- Alzheimer’s Disease and Other Dementias-Novel Therapeutic Approaches-2nd Edition (Deadline: 31 July 2021)
- Autoimmunity in the Nervous Systems: Multiple Sclerosis and Beyond (Deadline: 31 July 2021)
- Modulation of Neuronal Excitability, Synaptic Transmission, and Plasticity in Health and Disease 2.0 (Deadline: 31 July 2021)
- Neuropeptides, Receptors, and Behavior (Deadline: 31 July 2021)
- Steering Functional Pathways, Genomic and Non-genomic, to Keep Neurodegeneration in Check (Deadline: 31 July 2021)
- Nutritional and Inflammatory Biomarkers in Major Psychiatric Disorders (Deadline: 31 July 2021)
- The Role of Neuroimmune Inflammation in Chemotherapy-Induced Side Effects (Deadline: 31 July 2021)
- Stem Cells in Neurodegenerative Pathologies (Deadline: 31 July 2021)
- New Mechanisms and Therapeutics in Neurological Diseases (Deadline: 31 July 2021)
- Pathomechanism of Neurological and Neuropsychiatric Disorders, Neurodegeneration and Neuroprotection (Deadline: 31 August 2021)
- Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases (Deadline: 31 August 2021)
- Neuronal, Glial, and Immune Changes in Models of Epilepsy and Epileptogenesis-2nd Edition (Deadline: 31 August 2021)
- Mast Cells in Human Health and Diseases (Deadline: 31 August 2021)
- Molecular Mechanisms on Huntington's Disease (Deadline: 31 August 2021)
- Neurobiology of Aging and Aging-Related Disorders (Deadline: 31 August 2021)
- The Molecular Brain and Its Health (Deadline: 31 August 2021)
- Neuroprotective Effect of Glutathione (Deadline: 31 August 2021)
- The Pathogenesis and Therapeutic Strategies for Understanding and Treating Diabetic Neuropathy of the Retina (Deadline: 31 August 2021)
- Effects of Environmental Factors on the Nervous Tissue Functioning: Molecular Bases of Neuropathogenic Mechanisms (Deadline: 31 August 2021)
- Molecular Mechanisms Underlying Neuropsychiatric Disorders and Their Treatment (Deadline: 31 August 2021)
- Non-Coding RNAs in Human Neurodevelopmental Disorders and Brain Disorders (Deadline: 31 August 2021)
- Disorders of Cholesterol Homeostasis (Deadline: 31 August 2021)
- Novel In Vitro and In Silico Approaches to Study Developmental Neurotoxicity (Deadline: 31 August 2021)
- Molecular Treatment in Optic Neuropathies (Deadline: 31 August 2021)
- Astrocytes: Emerging Roles in the Pathogenesis and Treatment of CNS Disorders 2.0 (Deadline: 31 August 2021)
- Molecular and Cellular Signaling on Antidepressant Mechanisms (Deadline: 31 August 2021)
- Proteinopathies in Frontotemporal Lobar Degeneration (Deadline: 31 August 2021)
- Drosophila Models for Neurodegenerative Diseases: Achievements and Prospects (Deadline: 31 August 2021)
- Role of the Vasculature in Neurological Disease (Deadline: 1 September 2021)
- Parkinson's Disease and Related Disorders: Mechanisms, Biomarkers, and Models (Deadline: 15 September 2021)
- GABAergic Physiology in Neurological Disorders (Deadline: 29 September 2021)
- New Advances in Research on Alzheimer's Disease (Deadline: 30 September 2021)
- Molecular Mechanisms Employed by Neurons to Receive and Transduce Signals Essential for Learning and Memory (Deadline: 30 September 2021)
- Pharmaco-toxicological Effects of Novel Psychoactive Substances (Deadline: 30 September 2021)
- Natural and Artificial Vesicles against Brain Diseases (Deadline: 30 September 2021)
- Molecular Mechanisms, Pathophysiology and Phenotypes of Mitochondrial Disorders (Deadline: 30 September 2021)
- Prions and Prion Diseases 2.0 (Deadline: 30 September 2021)
- Newly Developed Drugs for Alzheimer's Disease (Deadline: 30 September 2021)
- CNS Injuries (Deadline: 30 September 2021)
- Microglia Heterogeneity and Its Relevance for Translational Research (Deadline: 30 September 2021)
- Immunology of Neuropsychiatric Disorders (Deadline: 30 September 2021)
- Role of Extracellular Matrix Molecules in CNS Injury, Aging and Neurodegenerative Disease (Deadline: 30 September 2021)
- Glial-Neuronal Interactions in Neurological Disorders: Molecular Mechanisms and Potential Points for Intervention 2.0 (Deadline: 30 September 2021)
- CNS Drug Action in Neurodegenerative Diseases 2.0 (Deadline: 30 September 2021)
- Neurodegenerative Diseases: From Molecular Basis to Therapy (Deadline: 30 September 2021)
- Disease Modifying Translational Research for Neurological Disorders and Brain Damages (Deadline: 30 September 2021)
- Molecular Mechanisms of Polyglutamine Diseases (Deadline: 30 September 2021)
- Molecular Mechanisms of Neural Circuit Development and Regeneration 2.0 (Deadline: 30 September 2021)
- Development of Dopaminergic Neurons (Deadline: 30 September 2021)
- Neuroinflammation in Parkinson's Disease (Deadline: 30 September 2021)
- Melatonin and Mitochondria (Deadline: 30 September 2021)
- Glioma: Molecular Aspects and Theranostics (Deadline: 29 October 2021)
- Oligodendrocyte Lineage Cells (Deadline: 31 October 2021)
- Mitochondrial Dynamics in Neurons (Deadline: 31 October 2021)
- Molecular Mechanisms and Pathophysiology of Cerebral Ischemia (Deadline: 31 October 2021)
- Molecular Mechanisms and Pharmacological Targeting of Neuroprotection (Deadline: 31 October 2021)
- Psychoneuropharmacology (Deadline: 31 October 2021)
- Alzheimer's disease: From Molecular Basis to Therapy (Deadline: 31 October 2021)
- Neuro–Immune Interactions in Health and Disease (Deadline: 31 October 2021)
- Connecting In Vitro, In Vivo, and Ex Vivo Studies in Neurodegenerative Diseases (Deadline: 31 October 2021)
- Molecular Research on Huntington’s Disease (Deadline: 31 October 2021)
- The Various Molecular Mechanisms Underlying Autism Spectrum Disorders (Deadline: 31 October 2021)
- The Involvement of Cholinergic and Norepinephrine Network Modulation in Alzheimer’s Disease Cognitive Dysfunction (Deadline: 31 October 2021)
- The Synaptic Vesicle Cycle as It Relates to Neurotransmitter Release at Nerve Terminals (Deadline: 31 October 2021)
- Gangliosides: Modes of Action and Cell Fates II (Deadline: 31 October 2021)
- Molecular Mechanisms of Neuronal Death in Neurodegeneration (Deadline: 31 October 2021)
- Biomarkers of Treatment Response in Psychiatric Disorders (Deadline: 30 November 2021)
- Neuroinflammation: From Molecular Basis to Therapy (Deadline: 30 November 2021)
- Neuroendocrine Factors in Health and Disease (Deadline: 30 November 2021)
- Neurolipids in Neurodegenerative Disorders (Deadline: 30 November 2021)
- Molecular Mechanism Underlying Rare Inherited Neurological Diseases (Deadline: 30 November 2021)
- Studying Functional and Molecular Connectome of the Human and Animal Brain (Deadline: 31 December 2021)
- Role of Natural Compounds in Neurological Diseases (Deadline: 31 December 2021)
Topical Collections
Following topical collections within this section are currently open for submissions:
